H. 12. provider for the most current information.The recipient will receive more details and instructions to access this offer.By clicking send, you acknowledge that you have permission to email the recipient with this information.The recipient will receive more details and instructions to access this offer.By clicking send, you acknowledge that you have permission to email the recipient with this information. 2002 DATE DE RÉDACTION : 17300, autoroute Transcanadienne le 24 août 1990 Kirkland (Québec) H9J 2M5 Diseases & Conditions If DIFLUCAN is kept during treatment or if the strict becomes pregnant while taking the area, esophagus hemorrhaging or incongruent. If DIFLUCAN is used during pregnancy or if the very becomes pregnant while no the mouth, candidiasis in infants exposed group bottom transplants and pneumonia in by food. Fluconazole is designated chemically as 2,4-difluoro-α,α.

Patients with rare hereditary problems to fructose intolerance, glucose/galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Canada Pharmacy . ), ceftriaxone, cefuroxime, chloramphenicol, clindamycin, co-trimoxazole, diazepam, digoxin, erythromycin lactobionate, furosemide, haloperidol, hydroxyzine, imipenem/cilastatin, pentamidine, piperacillin, ticarcillin, TMP-SMXAdditive: Acyclovir, amikacin, amphotericin B, cefazolin, ceftazidime, ciprofloxacin, clindamycin, gentamicin, heparin, meropenem, metronidazole, morphine, piperacillin, potassium chloride, ranitidine with ondansetron, theophyllineY-site: Acyclovir, aldesleukin, allopurinol, amifostine, amikacin, aminophylline, amiodarone, ampicillin-sulbactam, aztreonam, benztropine, bivalirudin, cefazolin, cefepime, cefotetan, cefoxitin, cefpirome, chlorpromazine, cimetidine, cisatracurium, dexamethasone sodium phosphate, dexmedetomidine, diltiazem, diphenhydramine, dobutamine, docetaxel, dopamine, doxorubicin liposomal, droperidol, etoposide PO4, famotidine, fenoldopam, filgrastim, fludarabine, foscarnet, ganciclovir, gatifloxacin, gemcitabine, gentamicin, granisetron, heparin, hetastarch, hydrocortisone, immune globulin, leucovorin, linezolid, lorazepam, melphalan, meperidine, meropenem, metoclopramide, metronidazole, midazolam, morphine, nafcillin, nitroglycerin, ondansetron, oxacillin, paclitaxel, pancuronium, penicillin G, phenytoin, piperacillin-tazobactam, prochlorperazine, promethazine, propofol, quinupristin-dalfopristin, ranitidine, remifentanil, sargramostim, tacrolimus, teniposide, theophylline, thiotepa, ticarcillin-clavulanate, tobramycin, vancomycin, vecuronium, vinorelbine, zidovudineStandard diluent: 200 mg/100 mL NS (premixed); 200 mg/200 mL NS (premixed)To prevent air embolism, do not connect in series with other infusionsDry powder: Store below 86° F (30°C); reconstituted suspension should be stored between 41-86° F (5-30°C), and unused portion should be discarded after 2 weeks; protect from freezingInjection (glass bottles): Store between 41-86° F (5-30°C); protect from freezingInjection (Viaflex Plus plastic containers): Store between 41-77° F (5-25°C); protect from freezingAdding plans allows you to compare formulary status to other drugs in the same class.To view formulary information first create a list of plans. essentially 'sodium-free'.

On l'utilise le plus fréquemment pour traiter les infections fongiques de la bouche (le muguet), de l'œsophage (le conduit dans lequel la nourriture passe de la gorge à l'estomac), des poumons, des voies urinaires et du vagin (une infection à levures). As others, as day-case narrowing. 200 mg PO on Day 1, THEN 100 mg qDay; doses up to 400 mg/day may be used based on patient’s responseDosage of up to 400 mg qDay may be used based on patient’s responseSuppression of relapse in patients with AIDS: 200 mg PO qDayPrevention of candidiasis incidence in patients undergoing bone marrow transplantRecurrent: 150 mg PO qDay for 10-14 days followed by 150 mg once weekly for 6 months6 mg/kg PO on Day 1, THEN 3 mg/kg qDay; not to exceed 600 mg/day Esophageal candidiasis: 6 mg/kg PO on Day 1, THEN 3 mg/kg qDay Doses up to 12 mg/kg/day may be used, based on patient’s responseDose of 12 mg/kg once daily may be used, based on patient’s responseSuppression in children with AIDS: 6 mg/kg once dailyConcurrent QT-prolonging drugs that are metabolized via the enzyme CYP3A4 (cisapride, erythromycin, pimozide, and quinidine)Use caution in proarrhythmic conditions and renal impairmentUse extreme caution or avoid in congenital long-QT patients and patients with conditions that increase QT-prolongation riskFluconazole inhibits CYP2C9, CYP2C19, and CYP3A4 isoenzymes; coadministration with drugs that are substrates if these isoenzymes may be contraindicated or warrant dosage modificationsCapsules contain lactose and should not be given to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorptionPowder for oral suspension contains sucrose and should not be used in patients with hereditary fructose, glucose/galactose malabsorption or sucrase-isomaltase deficiencySyrup contains glycerol; may cause headache, stomach upset, and diarrheaHepatotoxicity reported with use; use with caution in patients with hepatic impairmentRare exfoliative skin disorders reported; monitor closely if rash develops and discontinue if it progressesWhen driving vehicles or operating machines, it should be taken into account that dizziness or seizures may occasionally occurConvenience and efficacy of single dose oral tablet of fluconazole regimen for the treatment of vaginal yeast infections should be weighed against acceptability of higher incidence of drug related adverse events with fluconazole (26%) versus intravaginal agents (16%)If drug is used during pregnancy or if patient becomes pregnant while taking the drug, patient should be informed of potential hazard to fetus; effective contraceptive measures should be considered in women of child-bearing potential who are being treated with 400 to 800 mg/day and should continue throughout the treatment period and for approximately 1 week (5 to 6 half-lives) after the final doseSecreted in human milk at concentrations similar to maternal plasma concentrations; use caution (AAP Committee states "compatible with nursing") A: Generally acceptable.